[go: up one dir, main page]

Nairz et al., 2021 - Google Patents

Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics

Nairz et al., 2021

View HTML
Document ID
12512995280403610533
Author
Nairz M
Bellmann-Weiler R
Ladstaetter M
Schuellner F
Zimmermann M
Koller A
Blunder S
Naschberger H
Klotz W
Herold M
Kerndler S
Jeske M
Haschka D
Petzer V
Schroll A
Sonnweber T
Tancevski I
Fritsche G
de Araujo M
Stasyk T
Huber L
Griesmacher A
Theurl I
Weiss G
Publication year
Publication venue
Scientific Reports

External Links

Snippet

The diagnosis of COVID-19 relies on the direct detection of SARS-CoV-2 RNA in respiratory specimens by RT-PCR. The pandemic spread of the disease caused an imbalance between demand and supply of materials and reagents needed for diagnostic purposes including …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00178—Special arrangements of analysers
    • G01N2035/00326—Analysers with modular structure
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3493—Computer-assisted epidemiological alert systems, e.g. bioterrorism or flu alerts
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G06F19/366—Acquisition of data related to laboratory tests, e.g. special identifiers for examination containers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Azar et al. Detection of influenza A and B viruses and respiratory syncytial virus by use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-waived point-of-care assays: a paradigm shift to molecular tests
Teo et al. Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection
US11385252B2 (en) Systems and methods for analyte testing and laboratory oversight
Nairz et al. Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics
Peaper et al. Rapid diagnosis of influenza: state of the art
Weitzel et al. Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples
Bouzid et al. Systematic review on the association between respiratory virus real-time PCR cycle threshold values and clinical presentation or outcomes
Pitetti et al. Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children
Syal Guidelines on newly identified limitations of diagnostic tools for COVID‐19 and consequences
Hirotsu et al. Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients
Cohen et al. Accurate PCR detection of Influenza A/B and respiratory syncytial viruses by use of Cepheid Xpert Flu+ RSV Xpress Assay in point-of-care settings: comparison to Prodesse ProFlu+
Young et al. Diagnostic accuracy of the real-time PCR cobas® Liat® Influenza A/B assay and the Alere i Influenza A&B NEAR isothermal nucleic acid amplification assay for the detection of influenza using adult nasopharyngeal specimens
Guo et al. Recent advances in methods for the diagnosis of Corona Virus Disease 2019
Ortiz et al. Practical challenges of point-of-care testing
Mo et al. Quality management for point-of-care testing of pathogen nucleic acids: Chinese expert consensus
Gunell et al. Comprehensive real-time epidemiological data from respiratory infections in Finland between 2010 and 2014 obtained from an automated and multianalyte mariPOC® respiratory pathogen test
Fitoussi et al. Performances of the VitaPCR™ SARS‐CoV‐2 Assay during the second wave of the COVID‐19 epidemic in France
Youngs et al. Implementation of the cobas Liat influenza point-of-care test into an emergency department during a high-incidence season: a retrospective evaluation following real-world implementation
Hassan et al. Multicenter clinical evaluation of the Alere i respiratory syncytial virus isothermal nucleic acid amplification assay
Kittel et al. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
Caffry et al. The QuantuMDx Q-POC SARS-CoV-2 RT-PCR assay for rapid detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology
Daum et al. Rapid and safe detection of SARS-CoV-2 and influenza virus RNA using onsite quantitative PCR diagnostic testing from clinical specimens collected in molecular transport medium
Matsumura et al. Epidemiology of respiratory viruses according to age group, 2023–24 winter season, Kyoto, Japan
Markewitz et al. Cycle threshold of SARS-CoV-2 RT-PCR as a driver of retesting
Juniastuti et al. The evaluation results of proposed antigen rapid diagnostic tests for COVID-19: some possible factors might influence